scioUbi is a high-content protein expression and ubiquitination level analysis.
With scioUbi you can analyse up to 1,000 proteins in a single assay.
Features
|
Benefits for your research
|
 Biological processes |
 Cell cycle: proteins in green are covered by the analysis |
|
Biological effects of
|
Others
|
| June 2022 | In a study by Robert Labes et al. insights in prevention of cyclosporine mediated anemia and peritubular capillary loss were identified.
| June 2022 | In a study by D. Abdulkhalikova et al. Endometrial Proteome changes werde identified impacted by Lifestyle modification in woman with Polycystic Ovarian Syndrome and Obesity.
| May 2022 | In a study by Maja Pušić et al. Cycle-dependent plasma protein biomarkers for peritoneal endometriosis were identified by our scioDiscover platform.
| Jan 2022 | In a study by Valentina di Pietro at Birmingham University our scioDoiscover platform was used to analyse the co-expression of proteins and microRNAs in the brains of Alzheimer's disease patients.
| Jan 2022 | Erich Piovan and collegues at University of Padua collaborated with Sciomics to study specific biomarkers in FFPE tissue samples of DLBCL patients by custom antibody microarrays.
Dr. Bettina Grötsch
Department of Medicine 3 - Rheumatology and Immunology, University Clinics Erlangen, Erlangen, Germany
"Our lab is working with human osteoclast that were isolated and differentiated from human peripheral blood. Therefore, we were quite limited in cell numbers and protein content for our planned Phosphoprotein analyses. Nonetheless, Sciomics and especially Camille Lowy helped us a lot to test and improve our protein isolation techniques to achieve some interesting phosphoproteome data in human osteoclasts. We were really impressed by the detailed data report and their willingness to discuss and reanalyze the data repeatedly until we got the best results out of our measurements. Even several month after their first report, we could ask for help and suggestions with an immediate reply. The phosphoproteome analyses completed our preliminary project data and are now published in Frontiers Immunology. Altogether, we were very happy with the service of Sciomics and special thanks to Camille Lowy and Christoph Schröder who guided us through the whole process."
Product: scioPhospho
Publication: Grötsch B. et al. 2022 Front. Immunol. 13:958974
Alenka Djarmila Behsen, PhD candidate
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
"The process of working with Ronny and his colleagues at Sciomics has been very easy and efficient. Response time is very quick and they are always available for meetings when you have more questions. Would definitely recommend working with Sciomics."
Product: scioCD
RT @BioRNCluster: Disease Definition- Do we know enough? Current drugs - effective enough? Precise enough? Stratification of patients and p…
RT @BioRNCluster: 𝗕𝗶𝗼𝗥𝗡 𝗴𝗼𝗲𝘀 𝗕𝗶𝗼-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟯 by @EBDgroup With @BioLabs, @HeidelbergPharm, Polysciences, RHEACELL, @sciomics, Yuma…
@BioRNCluster @EBDgroup @biolabs @HeidelbergPharm Thank you @BioRNCluster for organising this joint booth. We are l… https://t.co/bmIUvyibLi
RT @RonnySchmidt84: @MCDS_Therapy @sciomics It is an absolute pleasure to be part of the great MCDS-Therapy consortium and to work towards…
RT @MCDS_Therapy: .@sciomics is an amazing partner! They've been a vital part of our #ClinicalTrial that's testing whether the drug #Carba…